BindingDB logo
myBDB logout

15 articles for Aventis Pharma Deutschland GmbH

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
15125936 Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand. 05-MAY-2004 12-DEC-2014
12570371 Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5. 06-FEB-2003 10-NOV-2009
11454469 alpha(v)beta(3) Antagonists based on a central thiophene scaffold. 16-JUL-2001 10-NOV-2009
12668013 Design, synthesis, and structure-activity relationship of a new class of amidinophenylurea-based factor VIIa inhibitors. 01-APR-2003 10-NOV-2009
15125940 Pharmacophore-based search, synthesis, and biological evaluation of anthranilic amides as novel blockers of the Kv1.5 channel. 05-MAY-2004 10-NOV-2009
11689069 Synthesis and activity of novel and selective I(Ks)-channel blockers. 05-NOV-2001 10-NOV-2009
15780605 QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands. 22-MAR-2005 10-NOV-2009
15203149 Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition. 18-JUN-2004 10-NOV-2009
16392792 Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis. 05-JAN-2006 10-NOV-2009
12036347 Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. 30-MAY-2002 10-NOV-2009
15734645 Structural basis for the highly selective inhibition of MMP-13. 00-FEB-2005 17-JUL-2007
15261269 Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand. 16-AUG-2004 27-MAY-2007
15261268 Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents. 16-AUG-2004 27-MAY-2007
12061878 Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa. 20-JUN-2002 17-FEB-2007
15857135 Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions. 05-MAY-2005 12-FEB-2007